Acorda Therapeutics
ACOR
#11221
Rank
C$1.16 M
Marketcap
C$0.93
Share price
0.00%
Change (1 day)
-95.57%
Change (1 year)

Earnings for Acorda Therapeutics (ACOR)

Earnings in 2024 (TTM): -C$0.37 Billion

According to Acorda Therapeutics 's latest financial reports the company's current earnings are C$0.11 Billion. In 2023 the company made an earning of -C$0.38 Billion a decrease over its 2022 earnings that were of -C$7.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Acorda Therapeutics from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.37 Billion-3.35%
2023 -C$0.38 Billion4848.63%
2022 -C$7.55 Million-93.25%
2021 -C$0.12 Billion2.52%
2020 -C$0.11 Billion-69.45%
2019 -C$0.36 Billion-700.62%
2018 C$59.41 M-118.02%
2017 -C$0.33 Billion805.99%
2016 -C$36.41 Million-173.88%
2015 C$49.27 M-6.58%
2014 C$52.74 M20.19%
2013 C$43.88 M18.7%
2012 C$36.96 M-26.54%
2011 C$50.32 M
2009 -C$0.12 Billion10.65%
2008 -C$0.11 Billion86.17%
2007 -C$55.79 Million68.1%
2006 -C$33.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
C$34.59 M-109.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.11 B-128.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
-C$0.11 Billion-71.86%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
C$0.54 B-241.88%๐Ÿ‡บ๐Ÿ‡ธ USA